相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cellular and molecular insights into incomplete immune recovery in HIV/AIDS patients
Liting Yan et al.
FRONTIERS IN IMMUNOLOGY (2023)
Efficient treatment and pre-exposure prophylaxis in rhesus macaques by an HIV fusion-inhibitory lipopeptide
Jing Xue et al.
CELL (2022)
IFN-α blockade during ART-treated SIV infection lowers tissue vDNA, rescues immune function, and improves overall health
Louise A. Swainson et al.
JCI INSIGHT (2022)
Combined multi-omics and network pharmacology approach reveals the role of Tripterygium Wilfordii Hook F in treating HIV immunological non-responders
Xiaosheng Liu et al.
PHYTOMEDICINE (2022)
Therapeutic effect of (5R)-5-hydroxytriptolide (LLDT-8) in SIV infected rhesus monkeys
Tingxia Lv et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
Neuroinflammatory transcriptional programs induced in rhesus pre-frontal cortex white matter during acute SHIV infection
Chase E. Hawes et al.
JOURNAL OF NEUROINFLAMMATION (2022)
Tripterygium wilfordii: An inspiring resource for rheumatoid arthritis treatment
Yanqiong Zhang et al.
MEDICINAL RESEARCH REVIEWS (2021)
HIV-Related Immune Activation and Inflammation: Current Understanding and Strategies
Tingxia Lv et al.
Journal of Immunology Research (2021)
Triptolide analog LLDT-8 ameliorates psoriasis-like dermatitis in BALB/c mice via suppressing the IL-36α signaling pathway
Qing Qi et al.
PHARMACOLOGICAL RESEARCH (2021)
The role of CD38 in HIV infection
Liqi Lu et al.
AIDS RESEARCH AND THERAPY (2021)
Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART
Maria Pino et al.
PLOS PATHOGENS (2021)
Stage-Dependent Within-Individual Comparison Reveals SIV-Specific Activation/Exhaustion Shift in Rhesus Macaques
Ling Tong et al.
FRONTIERS IN MICROBIOLOGY (2021)
RNA Identification of PRIME Cells Predicting Rheumatoid Arthritis Flares
Dana E. Orange et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19
Joana P. Bernardes et al.
IMMUNITY (2020)
Immune Activation, Inflammation, and Non-AIDS Co-Morbidities in HIV-Infected Patients under Long-Term ART
Sonia Zicari et al.
VIRUSES-BASEL (2019)
Triptolide and Its Derivatives as Cancer Therapies
Pawan Noel et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou et al.
NATURE COMMUNICATIONS (2019)
Clinical characteristics of HIV-1-infected patients with high levels of plasma interferon-γ: a multicenter observational study
Dai Watanabe et al.
BMC INFECTIOUS DISEASES (2019)
Activated dendritic cells and monocytes in HIV immunological nonresponders: HIV-induced interferon-inducible protein-10 correlates with low future CD4(+) recovery
Birgitte Stiksrud et al.
AIDS (2019)
Elevated Level of CD4+ T Cell Immune Activation in Acutely HIV-1-Infected Stage Associates With Increased IL-2 Production and Cycling Expression, and Subsequent CD4+ T Cell Preservation
Huan Xia et al.
FRONTIERS IN IMMUNOLOGY (2018)
Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection
Irini Sereti et al.
CLINICAL INFECTIOUS DISEASES (2017)
Triptolide inhibits tumor growth by induction of cellular senescence
Ruidong Li et al.
ONCOLOGY REPORTS (2017)
Critical Role of Hepatic Cyp450 sin the Testis-Specific Toxicity of (5R)-5-Hydroxytriptolide in C57BL/6 Mice
Cunzhi Yu et al.
FRONTIERS IN PHARMACOLOGY (2017)
Toxicity of triptolide and the molecular mechanisms involved
Chen Xi et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Non-human primates in HIV research: Achievements, limits and alternatives
Thalia Garcia-Tellez et al.
INFECTION GENETICS AND EVOLUTION (2016)
Immune activation and HIV: an enduring relationship
Irini Sereti et al.
CURRENT OPINION IN HIV AND AIDS (2016)
Tripterygium wilfordii Hook F extract in cART-treated HIV patients with poor immune response: a pilot study to assess its immunomodulatory effects and safety
Taisheng Li et al.
HIV CLINICAL TRIALS (2015)
Covalent Modification of a Cysteine Residue in the XPB Subunit of the General Transcription Factor TFIIH Through Single Epoxide Cleavage of the Transcription Inhibitor Triptolide
Qing-Li He et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study
Patrick Miailhes et al.
JOURNAL OF HEPATOLOGY (2014)
Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression
Netanya G. Sandler et al.
NATURE (2014)
iRegulon: From a Gene List to a Gene Regulatory Network Using Large Motif and Track Collections
Rekin's Janky et al.
PLOS COMPUTATIONAL BIOLOGY (2014)
HIV-associated chronic immune activation
Mirko Paiardini et al.
IMMUNOLOGICAL REVIEWS (2013)
Programmed Death-1 Is a Marker for Abnormal Distribution of Naive/Memory T Cell Subsets in HIV-1 Infection
Gaelle Breton et al.
JOURNAL OF IMMUNOLOGY (2013)
Immunosuppressant discovery from Tripterygium wilfordii Hook f: the novel triptolide analog (5R)-5-hydroxytriptolide (LLDT-8)
Wei Tang et al.
ACTA PHARMACOLOGICA SINICA (2012)
Immune Activation in the Pathogenesis of Treated Chronic HIV Disease: A Workshop Summary
Susan F. Plaeger et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2012)
Triptolide Transcriptionally Represses HER2 in Ovarian Cancer Cells by Targeting NF-κB
Chien-Chih Ou et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2012)
Plasma IP-10 Is Associated with Rapid Disease Progression in Early HIV-1 Infection
Yanmei Jiao et al.
VIRAL IMMUNOLOGY (2012)
Sample-level enrichment analysis unravels shared stress phenotypes among multiple cancer types
Gunes Gundem et al.
GENOME MEDICINE (2012)
XPB, a subunit of TFIIH, is a target of the natural product triptolide
Denis V. Titov et al.
NATURE CHEMICAL BIOLOGY (2011)
Triptolide (TPL) Inhibits Global Transcription by Inducing Proteasome-Dependent Degradation of RNA Polymerase II (Pol II)
Ying Wang et al.
PLOS ONE (2011)
(5R)-5-hydroxytriptolide inhibits the immune response of human peripheral blood mononuclear cells
Ru Zhou et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Chronic innate immune activation as a cause of HIV-1 immunopathogenesis
Adriano Boasso et al.
CLINICAL IMMUNOLOGY (2008)
(5R)-5-hydroxytriptolide inhibits IFN-γ-related signaling
Ru Zhou et al.
ACTA PHARMACOLOGICA SINICA (2006)
(5R)-5-hydroxytriptolide attenuated collagen-induced arthritis in DBA/1 mice via suppressing interferon-γ production and its related signaling
Ru Zhou et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages
R Zhou et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
(5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide derivative, prevents experimental autoimmune encephalomyelitis via inhibiting T cell activation
Yun-Feng Fu et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
(5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide analog mediates immunosuppressive effects in vitro and in vivo
R Zhou et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2005)
Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cells
W Tang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2005)
分享论文
